Literature DB >> 26859077

The landscape of myeloid neoplasms with isochromosome 17q discloses a specific mutation profile and is characterized by an accumulation of prognostically adverse molecular markers.

M Meggendorfer1, C Haferlach1, M Zenger1, K Macijewski1, W Kern1, T Haferlach1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26859077     DOI： 10.1038/leu.2016.21

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  14 in total

1.  Isochromosome 17q in MDS: a marker of a distinct entity.

Authors:  Ronald Feitosa Pinheiro; Maria de Lourdes L F Chauffaille; Maria Regina Régis Silva
Journal:  Cancer Genet Cytogenet       Date:  2006-04-15

2.  Clinicopathologic and molecular characterization of myeloid neoplasms harboring isochromosome 17(q10).

Authors:  Valeria Visconte; Ali Tabarroki; Li Zhang; Edy Hasrouni; Chris Gerace; Robyn Frum; Jing Ai; Anjali S Advani; Hien K Duong; Matt Kalaycio; Yogen Saunthararajah; Mikkael A Sekeres; Eric D His; Shashirekha Shetty; Heesun J Rogers; Ramon V Tiu
Journal:  Am J Hematol       Date:  2014-05-16       Impact factor: 10.047

3.  Isochromosome 17q in blast crisis of chronic myeloid leukemia and in other hematologic malignancies is the result of clustered breakpoints in 17p11 and is not associated with coding TP53 mutations.

Authors:  T Fioretos; B Strömbeck; T Sandberg; B Johansson; R Billström; A Borg; P G Nilsson; H Van Den Berghe; A Hagemeijer; F Mitelman; M Höglund
Journal:  Blood       Date:  1999-07-01       Impact factor: 22.113

4.  Frequent pathway mutations of splicing machinery in myelodysplasia.

Authors:  Kenichi Yoshida; Masashi Sanada; Yuichi Shiraishi; Daniel Nowak; Yasunobu Nagata; Ryo Yamamoto; Yusuke Sato; Aiko Sato-Otsubo; Ayana Kon; Masao Nagasaki; George Chalkidis; Yutaka Suzuki; Masashi Shiosaka; Ryoichiro Kawahata; Tomoyuki Yamaguchi; Makoto Otsu; Naoshi Obara; Mamiko Sakata-Yanagimoto; Ken Ishiyama; Hiraku Mori; Florian Nolte; Wolf-Karsten Hofmann; Shuichi Miyawaki; Sumio Sugano; Claudia Haferlach; H Phillip Koeffler; Lee-Yung Shih; Torsten Haferlach; Shigeru Chiba; Hiromitsu Nakauchi; Satoru Miyano; Seishi Ogawa
Journal:  Nature       Date:  2011-09-11       Impact factor: 49.962

5.  Isolated isochromosome 17q: a distinct type of mixed myeloproliferative disorder/myelodysplastic syndrome with an aggressive clinical course.

Authors:  R F McClure; G W Dewald; J D Hoyer; C A Hanson
Journal:  Br J Haematol       Date:  1999-08       Impact factor: 6.998

6.  Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.

Authors:  Rocco Piazza; Simona Valletta; Nils Winkelmann; Sara Redaelli; Roberta Spinelli; Alessandra Pirola; Laura Antolini; Luca Mologni; Carla Donadoni; Elli Papaemmanuil; Susanne Schnittger; Dong-Wook Kim; Jacqueline Boultwood; Fabio Rossi; Giuseppe Gaipa; Greta P De Martini; Paola Francia di Celle; Hyun Gyung Jang; Valeria Fantin; Graham R Bignell; Vera Magistroni; Torsten Haferlach; Enrico Maria Pogliani; Peter J Campbell; Andrew J Chase; William J Tapper; Nicholas C P Cross; Carlo Gambacorti-Passerini
Journal:  Nat Genet       Date:  2012-12-09       Impact factor: 38.330

7.  Mutations and prognosis in primary myelofibrosis.

Authors:  A M Vannucchi; T L Lasho; P Guglielmelli; F Biamonte; A Pardanani; A Pereira; C Finke; J Score; N Gangat; C Mannarelli; R P Ketterling; G Rotunno; R A Knudson; M C Susini; R R Laborde; A Spolverini; A Pancrazzi; L Pieri; R Manfredini; E Tagliafico; R Zini; A Jones; K Zoi; A Reiter; A Duncombe; D Pietra; E Rumi; F Cervantes; G Barosi; M Cazzola; N C P Cross; A Tefferi
Journal:  Leukemia       Date:  2013-04-26       Impact factor: 11.528

8.  Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia.

Authors:  Véronique Gelsi-Boyer; Virginie Trouplin; José Adélaïde; Julien Bonansea; Nathalie Cervera; Nadine Carbuccia; Arnaud Lagarde; Thomas Prebet; Meyer Nezri; Danielle Sainty; Sylviane Olschwang; Luc Xerri; Max Chaffanet; Marie-Joëlle Mozziconacci; Norbert Vey; Daniel Birnbaum
Journal:  Br J Haematol       Date:  2009-04-15       Impact factor: 6.998

9.  Prognostic score including gene mutations in chronic myelomonocytic leukemia.

Authors:  Raphaël Itzykson; Olivier Kosmider; Aline Renneville; Véronique Gelsi-Boyer; Manja Meggendorfer; Margot Morabito; Céline Berthon; Lionel Adès; Pierre Fenaux; Odile Beyne-Rauzy; Norbert Vey; Thorsten Braun; Torsten Haferlach; François Dreyfus; Nicholas C P Cross; Claude Preudhomme; Olivier A Bernard; Michaela Fontenay; William Vainchenker; Susanne Schnittger; Daniel Birnbaum; Nathalie Droin; Eric Solary
Journal:  J Clin Oncol       Date:  2013-05-20       Impact factor: 44.544

Review 10.  Isochromosomes in neoplasia.

Authors:  F Mertens; B Johansson; F Mitelman
Journal:  Genes Chromosomes Cancer       Date:  1994-08       Impact factor: 5.006
View more
  5 in total

1.  Pediatric acute myeloid leukemia patients with i(17)(q10) mimicking acute promyelocytic leukemia: Two case reports.

Authors:  Hong-Xia Yan; Wei-Hua Zhang; Jin-Quan Wen; Yan-He Liu; Bao-Juan Zhang; A-Duo Ji
Journal:  World J Clin Cases       Date:  2022-06-06       Impact factor: 1.534

Review 2.  Clinical and Molecular Approach to Adult-Onset, Neoplastic Monocytosis.

Authors:  Rory M Shallis; Alexa J Siddon; Amer M Zeidan
Journal:  Curr Hematol Malig Rep       Date:  2021-04-22       Impact factor: 3.952

3.  Myeloid Neoplasms with Isolated Isochromosome 17q: a yet to be Defined Entity.

Authors:  Eleftheria Lamprianidou; Chryssoula Kordella; Menelaos Papoutselis; Zoi Bezyrgiannidou; Evangelia Nakou; Spyros Papamichos; Emmanouil Spanoudakis; Andreas Giannopoulos; Katerina Zoi; Ioannis Kotsianidis
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-11-01       Impact factor: 2.576

4.  Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group.

Authors:  Rashmi Kanagal-Shamanna; Attilio Orazi; Robert P Hasserjian; Daniel A Arber; Kaaren Reichard; Eric D Hsi; Adam Bagg; Heesun Joyce Rogers; Julia Geyer; Faezeh Darbaniyan; Kim-Anh Do; Kyle M Devins; Olga Pozdnyakova; Tracy I George; Paola Dal Cin; Patricia T Greipp; Mark J Routbort; Keyur Patel; Guillermo Garcia-Manero; Srdan Verstovsek; L Jeffrey Medeiros; Sa A Wang; Carlos Bueso-Ramos
Journal:  Mod Pathol       Date:  2021-11-13       Impact factor: 7.842

5.  Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRAS.

Authors:  Rashmi Kanagal-Shamanna; Rajyalakshmi Luthra; Cameron C Yin; Keyur P Patel; Koichi Takahashi; Xinyan Lu; John Lee; Chong Zhao; Francesco Stingo; Zhuang Zuo; Mark J Routbort; Rajesh R Singh; Patricia Fox; Farhad Ravandi; Guillermo Garcia-Manero; L Jeffrey Medeiros; Carlos E Bueso-Ramos
Journal:  Oncotarget       Date:  2016-03-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.